Abstract
AbstractIdeas about precision medicine found its way into cancer research around the turn of the twentieth century and resulted in the imaginary of precision oncology. This chapter presents the emergence of the imaginary as well as its historical background. It furthermore argues that the imaginary is not well suited to take full biological complexity into account. This gives rise to conceptual limitations as well as practical risks as ambitions of precision are translated into practice.
Publisher
Springer International Publishing